It didn’t take long for the Biden administration to answer criticism that the United States wasn’t doing enough to ease the world’s COVID-19 vaccination shortfall.
On Thursday, White House COVID response coordinator Jeff Zients revealed that the government has earmarked $2.7 billion to beef up vaccine manufacturing.
Zients did not discuss details of the plan—such as which companies would receive the aid—but he did say that the funds will boost production of key supplies to produce the shots. Some of those materials include bioreactor bags, tubing, lipids, vials, needles and syringes, Bloomberg and The New York Times report, citing officials familiar with the plan.
